What Happened?
San Diego, CA-based Abzena Appointed Andrew Kraus as Chief Technology Officer
About the Company
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US. Abzena`s complimentary services and technologies in chemistry, biology and manufacturing, are applied to the selection, development and manufacture of better biopharmaceuticals. Abzena works with most of the top 20 biopharmaceutical companies and academic groups around the world, and has enabled many of them to progress products (Abzena inside), through to clinical development. Abzena`s teams at the Babraham Research Campus, Cambridge, UK, in San Diego, CA and Bristol, PA in the US are focused on developing better treatments for patients.
About the Person
Andrew Kraus is Chief Technology Officer at Clinical ink. Previously, Andrew held various senior IT leadership roles in the industry.
Info Source
News
Short Profile